Parkin is linked to the ubiquitin pathway

Journal of Molecular Medicine

Volumn 79, Issue 9, 2001, Pages 482-494

  Tanaka, Keiji ^a   Suzuki, Toshiaki ^a   Chiba, Tomoki ^a   Shimura, Hideki ^b   Hattori, Nobutaka ^b   Mizuno, Yoshikuni ^b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autosomal recessive juvenile parkinsonism; Lewy body; Neurodegenerative disorder; Parkin; Parkinson's disease

Indexed keywords

UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE;

AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DEGENERATIVE DISEASE; GENE FUNCTION; GENE MUTATION; GENETIC CODE; HUMAN; LEWY BODY; NERVE CELL NECROSIS; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REVIEW; SUBSTANTIA NIGRA;

ANIMALS; BRAIN; HUMANS; LIGASES; MODELS, BIOLOGICAL; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 0034808577     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090100242     Document Type: Review

References (84)

1. Medical progress: Parkinson's disease
2. Pathology and biology of Lewy body
3. Progress in the clinical and molecular genetics of familial parkinsonism
4. Mutation in the α-synuclein gene identified in families with Parkinson's disease
5. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
6. The ubiquitin pathway in Parkinson's disease
7. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe
8. Association between early-onset Parkinson's disease and mutations in the parkin gene
9. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms
10. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism
11. Clinical, pathologic, and genetic studies on autosomal recessive early-onset parkinsonism with diurnal fluctuation
12. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
13. Ubiquitin and the molecular pathology of human disease
14. α-Synuclein in Lewy bodies
15. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
16. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases
17. The ubiquitin system
18. Ubiquitin-dependent protein degradation
19. The ubiquitin system
20. Protein ubiquitination involving an E1-E2-E3 enzyme thioester cascade
21. RING domains: Master builders of molecular scaffolds?
22. Ubiquitination: RING for destruction?
23. SCF and Cullin/RING-H2-based ubiquitin-ligases
24. RING finger proteins: Mediators of ubiquitin ligase activity
25. The lore of the RINGs: Substrate recognition and catalysis by ubiquitin ligases
26. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes
27. Deubiquitinating enzymes: Their diversity and emerging roles
28. Structure and functions of the 20S and 26S proteasomes
29. The 26S proteasome
30. The 26S proteasome: A molecular machine designed for controlled proteolysis
31. The proteasome
32. The base of the proteasome regulatory particle exhibits chaperone-like activity
33. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
34. Intracellular inclusions and the ubiquitin-proteasome pathway: Digestion of a red herring?
35. Aggresomes, inclusion bodies and protein aggregation
36. Localization of a gene for autosomal recessive form of juvenile parkinsonism (AR-JP) to chromosome 6q25.2-27
37. Does failure of parkin-mediated ubiquitination cause juvenile parkinsonism?
38. A novel transactivation domain in parkin
39. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases
40. A family of structurally related RING finger proteins interacts specifically with the ubiquitin-conjugating enzyme UbcM4
41. Ariadne-1: A vital Drosophila gene is required in development and defines a new conserved family of RING-finger proteins
42. The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1
43. Homodimer of two F-box proteins βTrCP1 or βTrCP2 binds to IκBα for signal-dependent ubiquitination
44. The ligation systems for ubiquitin and ubiquitin-like proteins
45. Ubiquitin and its kin: How close are the family ties?
46. Evolution and function of ubiquitin-like protein-conjugation system
47. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome
48. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity
49. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
50. Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism
51. Activity of MDM 2 is a RING finger-dependent ubiquitin protein ligase, toward p53 or itself is dependent on the RING finger domain of the ligase
52. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
53. Molecular cloning and characterization of a novel protein kinase C-interacting protein with structural motifs related to RBCC family proteins
54. β-Catenin as oncogene: The smoking gun
55. Understanding cell death in Parkinson's disease
56. Oxidative stress in nigral cell death in Parkinson's disease
57. Mitochondrial dysfunction in Parkinson's disease
58. Mitochondria and apoptosis
59. Mechanism of MPTP toxicity
60. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
61. Polyglutamine expansions: Proteolysis, chaperones, and the dangers of promiscuity
62. Reversing neurodegeneration: A promise unfolds
63. Triggering of neuronal cell death by accumulation of activated SK1 on nuclear polyglutamine aggregations in PML bodies
64. UBE3A/E6-AP mutations cause Angelman syndrome
65. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
66. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
67. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
68. II130, interfering with CREB-dependent transcription
69. Immunohistochemical and sub-cellular localization of Parkin: Absence of protein in AR-JP patients
70. Parkin is associated with actin filaments in neuronal and nonneuronal cells
71. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
72. Is there a cause-and effect relationship between α-synuclein fibrillization and Parkinson's disease?
73. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
74. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity
75. New animal models for Parkinson's disease
76. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
77. A Drosophila model of Parkinson's disease
78. Degradation of α-synuclein by proteasome
79. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
80. Synphilin-1 is present in Lewy bodies in Parkinson's disease
81. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
82. Identification and distribution of parkin in rat brain
83. Cloning of rat parkin cDNA and distribution of parkin in rat brain
84. Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease